$KALV news
The latest KALV stock news: headlines, filings, AI summaries and sentiment for $KALV, updated around the clock.
- KalVista's Chief Development Officer Sells Shares Worth $905,000
- KalVista's Chief Development Officer Sells Shares Worth $905,000
- KalVista Pharmaceuticals Surges Following Acquisition Announcement by Chiesi Group
- KalVista Pharmaceuticals Surges on Acquisition Announcement by Chiesi Group
- KalVista Pharmaceuticals Reports Strong Early Performance for EKTERLY with $50M Revenue in Six Months